Peptide Library

Not FDA-approved

Hormones & metabolism

Tesamorelin (off-label)

Evidence

Limited human data

Class

Growth hormone-releasing hormone analog

/

Tesamorelin (off-label)

KEY TAKEAWAY

Tesamorelin is a 44-amino-acid analog of growth hormone-releasing hormone. The approved product is Egrifta. This entry covers off-label and compounded use. Only Egrifta is FDA-approved, for reducing excess abdominal fat in adults with HIV and lipodystrophy. Compounded or off-label uses are not FDA-approved.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Growth hormone-releasing hormone analog

Main uses

Approved for HIV-related abdominal fat; off-label uses are not proven

Key fact

Only Egrifta is FDA-approved, for reducing excess abdominal fat in adults with HIV and lipodystrophy. Compounded or off-label uses are not FDA-approved.

Route

Daily subcutaneous injection

Evidence strength

Limited human data

What it is

What it is

Tesamorelin is a 44-amino-acid analog of growth hormone-releasing hormone. The approved product is Egrifta. This entry covers off-label and compounded use.

How it works

How it works

It stimulates the pituitary gland to release growth hormone, which raises IGF-1.

Regulatory status

Regulatory status

Only Egrifta is FDA-approved, for reducing excess abdominal fat in adults with HIV and lipodystrophy. Compounded or off-label uses are not FDA-approved.

What it is used for

What it is used for

Approved for HIV-related abdominal fat; off-label uses are not proven.

Side effects and risks

Side effects and risks

Joint pain, fluid retention, higher blood sugar and injection-site reactions are possible. Raised IGF-1 levels need monitoring.

Citations

Citations

Tesamorelin (off-label): see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo